Back
Recruit Holdings Vs. Ascendis Pharma AS Industry Stock Comparison
Sell
31
RCRUY
Recruit Holdings
Last Price:
$11.00
Seasonality Move:
11.95%
Sell
48
ASND
Ascendis Pharma AS
Last Price:
$166.13
Seasonality Move:
-9.72%
Sell
31
Recruit Holdings (RCRUY)
is a Sell
Is Recruit Holdings a Buy, Sell or Hold?
-
The current Recruit Holdings [RCRUY] share price is $10.70. The Score for RCRUY is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
RCRUY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
-
The current Ascendis Pharma AS [ASND] share price is $164.65. The Score for ASND is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RCRUY Stock Price Chart
What is Recruit Holdings's stock price today?
-
The Recruit Holdings share price today is $10.70Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCRUY is experiencing slight selling pressure.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $164.65Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.
RCRUY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.62 | Sell |
| Relative Strength Index (14 RSI): | 23.47 | Sell |
| Chaikin Money Flow: | -108192 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.62 - 13.46) | Sell |
| Bollinger Bands (100): | (12.26 - 14.32) | Sell |
ASND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.96 | Buy |
| Relative Strength Index (14 RSI): | 63.68 | Buy |
| Chaikin Money Flow: | -280747 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (135.08 - 160.62) | Buy |
| Bollinger Bands (100): | (124.26 - 145.68) | Buy |
RCRUY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.67 | Sell |
| 20-day SMA: | 12.21 | Sell |
| 50-day SMA: | 13.23 | Sell |
| 200-day SMA: | 12.38 | Sell |
| 8-day EMA: | 11.5 | Sell |
| 20-day EMA: | 12.15 | Sell |
| 50-day EMA: | 12.86 | Sell |
| 200-day EMA: | 12.17 | Sell |
ASND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 154.01 | Buy |
| 20-day SMA: | 153.39 | Buy |
| 50-day SMA: | 139.38 | Buy |
| 200-day SMA: | 134.63 | Buy |
| 8-day EMA: | 157.06 | Buy |
| 20-day EMA: | 151.09 | Buy |
| 50-day EMA: | 143.18 | Buy |
| 200-day EMA: | 134.95 | Buy |
Recruit Holdings Earnings Growth & RCRUY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.82 per share, an increase next quarter of $0.04 per share, an increase this year of $3.21 per share, and an increase next year of $5.31 per share.
Recruit Holdings Technical Analysis
| Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ascendis Pharma AS Technical Analysis
| Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||